Selected Publications

 Linge A, et al.: The value of subcutaneous xenografts for individualized radiotherapy in HNSCC: robust gene signature correlates with radiotherapy outcome in patients and xenografts, Radiother Oncol (2023)

Löck S, et al.: Biomarker signatures for primary radiochemotherapy of locally advanced HNSCC - Hypothesis generation on a multicentre cohort of the DKTK-ROG  PMID: 35182686 DOI: 10.1016/j.radonc.2022.02.009 

Willers H, et al.: Screening and Validation of Molecular Targeted Radiosensitizers, Int J Radiat Oncol Biol Phys (2021) 

Seidlitz A, et al.: Final results of the prospective biomarker trial PETra: [11C]-MET-accumulation in postoperative PET/MRI predicts outcome after radiochemotherapy in glioblastoma, Clin Cancer Res. (2021)

 Soltwedel J, Suckert T, Beyreuther E, Schneider M, Boucsein M, Bodenstein E, Nexhipi S, Stolz-Kieslich L, Krause M, von Neubeck C, Haase R, Lühr A*, Dietrich A*. Slice2Volume: Fusion of multimodal medical imaging and light microscopy data of irradiation-injured brain tissue in 3D. Radiother Oncol. 2023 May;182:109591.

Naumann M, Czempiel T, Lößner AJ, Pape K, Beyreuther E, Löck S, Drukewitz S, Hennig A, von Neubeck C, Klink B, Krause M, William D, Stange DE, Bütof R, Dietrich A. Combined Systemic Drug Treatment with Proton Therapy: Investigations on Patient-Derived Organoids. Cancers (Basel). 2022 Aug 3;14(15):3781.

Suckert T, et al.: Late Side Effects in Normal Mouse Brain Tissue After Proton Irradiation, Front Oncol (2021)

Dietrich A, et al.: Radiotherapy enhances uptake and efficacy of 90Y-Cetuximab: a preclinical trial. Radiother Oncol, (2021)

Suckert T, et al.: Applying Tissue Slice Culture in Cancer Research-Insights from Preclinical Proton Radiotherapy. Cancers (Basel). 2020 Jun 16;12(6):1589. doi: 10.3390/cancers12061589.